Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
South Korea · Delayed Price · Currency is KRW 6,300.00
+250.00 (4.13%)
Jun 29, 2026, 3:30 PM KST
Hyundai Pharmaceutical Market Cap
Hyundai Pharmaceutical has a market cap or net worth of 174.37 billion as of June 29, 2026. Its market cap has increased by 83.14% in one year.
Market Cap
174.37B
Enterprise Value
n/a
Revenue
108.14B
Ranking
n/a
PE Ratio
104.41
Stock Price
6,300.00
Market Cap Chart
Since August 30, 1995, Hyundai Pharmaceutical's market cap has increased from 28.77B to 174.37B, an increase of 505.98%. That is a compound annual growth rate of 6.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 174.37B | -26.06% |
| Dec 30, 2025 | 235.81B | 137.66% |
| Dec 30, 2024 | 99.22B | -12.77% |
| Dec 28, 2023 | 113.76B | -14.20% |
| Dec 29, 2022 | 132.58B | -19.22% |
| Dec 30, 2021 | 164.12B | -22.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Suheung | 180.41B |
| REYON Pharmaceutical | 179.56B |
| Chong Kun Dang Holdings | 174.71B |
| Whan In Pharm | 170.61B |
| JW Lifescience | 170.02B |
| BNC KOREA | 165.86B |
| HLB Pharmaceutical | 157.41B |
| Daewon Pharmaceutical | 156.46B |